Clinical Trial - Trial jRCT2031220104
Access comprehensive clinical trial information for jRCT2031220104 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharma. K.K. and is currently Recruitment Completed. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031220104
Recruitment Completed
Trial Details
Japan Registry Clinical Trial • jRCT2031220104
Untitled Trial
PSMAddition: An International Prospective Open label, Randomized, Phase III Study comparing 177Lu PSMA 617 incombination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic HormoneSensitive Prostate Cancer (mHSPC) (PSMAddition)
Study Focus
Interventional
Sponsor & Location
Novartis Pharma. K.K.
United States of America;Austria;Belgium;Canada;Denmark;France;South Korea;Netherlands;Poland;Singap
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
Japan Registry Clinical Trial
jRCT2031220104
Non-Device Trial